Post by Jurgi Camblong

🧬 What does it take to move AI in medicine from an impressive demo to a trusted tool at the bedside? 🧠 What can centenarians and supercentenarians teach us about the biology of resilience? 🔬 How do breakthroughs like BRAF mutations in melanoma "connect the dots" for an entire generation of targeted therapies? 🚀 What does it really take to build a category-defining company — in healthcare or beyond? Guests like Dr. Michael Snyder (Stanford), Dr. David Rhew, M.D. (Microsoft), Parminder Bhatia (GE HealthCare), Prof. Mayana Zatz (USP), Dr. Pedram Razavi (MSK), Dr. Keith Flaherty (AACR), Umberto Malapelle (University of Naples Federico II), Prof. Nicholas Proudfoot (University of Oxford), Prof. Olivier Michielin (Geneva University Hospital & EPFL), Thomas Fuchs (Eli Lilly), Edouard Bugnion (VMware & EPFL), and Bernard Liautaud (Balderton Capital) have helped us go beyond the buzz and get to what's actually working — and what it takes to scale it. That's the whole idea behind Decoded: making the science and strategy behind data-driven medicine radically accessible, one honest conversation at a time. Here's to season two. 🎉 If you haven't yet, now's the moment to hit subscribe — new episodes are coming, and you won't want to miss what's next. 🎧 Listen and subscribe: https://lnkd.in/e-DytCm7 #DecodedPodcast #DataDrivenMedicine #PrecisionMedicine #AIinHealthcare #SOPHiAGENETICS

Video Content